Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
38%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
2
22%
Ph phase_1
6
67%
Ph phase_3
1
11%

Phase Distribution

6

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
6(66.7%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (66.7%)
Phase 22 (22.2%)
Phase 31 (11.1%)

Trials by Status

completed889%
terminated111%

Recent Activity

0 active trials
Showing 5 of 9
terminatedphase_2

Open-Label Study of Oral Treprostinil in Digital Ulcers

NCT00848107
completedphase_3

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

NCT01934582
completedphase_2

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

NCT00775463
completedphase_1

Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis

NCT00848939
completedphase_1

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

NCT01165476
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT00848107Phase 2

Open-Label Study of Oral Treprostinil in Digital Ulcers

Terminated
NCT01934582Phase 3

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

Completed
NCT00775463Phase 2

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Completed
NCT00848939Phase 1

Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis

Completed
NCT01165476Phase 1

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

Completed
NCT01172496Phase 1

A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers

Completed
NCT01153386Phase 1

Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine

Completed
NCT00963001Phase 1

Effect of Food on the Pharmacokinetics of Oral Treprostinil

Completed
NCT00963027Phase 1

Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9